Clinicopathological significance of WT1 expression in ovarian cancer: A possible accelerator of tumor progression in serous adenocarcinoma

Virchows Archiv

Volumn 451, Issue 1, 2007, Pages 27-35

  Yamamoto, Sohei ^a   Tsuda, Hitoshi ^a,c   Kita, Tsunekazu ^a   Maekawa, Kazunari ^a   Fujii, Kazuyuki ^a   Kudoh, Kazuya ^a   Furuya, Kenichi ^a   Tamai, Seiichi ^a   Inazawa, Johji ^b,c   Matsubara, Osamu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Medical and Dental University ^*  (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Ovarian carcinoma; Ovarian serous adenocarcinoma; Prognostic factor; Tumor progression; WT1

Indexed keywords

MESSENGER RNA; WT1 PROTEIN;

ARTICLE; CHEMISTRY; CYSTADENOCARCINOMA; DISEASE COURSE; FEMALE; GENETICS; HUMAN; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OVARY TUMOR; PATHOLOGY;

CYSTADENOCARCINOMA, SEROUS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; RNA, MESSENGER; WT1 PROTEINS;

EID: 35748982942     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-007-0433-4     Document Type: Article

References (42)

1. Acs G, Pasha T, Zhang PJ (2004) WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 23:110-118 (Pubitemid 38391769)
2. Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ (1996) A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005-1014 (Pubitemid 26104442)
3. Berker B, Dunder I, Ensari A, Cengiz SD (2002) Prognostic value of p53 accumulation in epithelial ovarian carcinomas. Arch Gynecol Obstet 266:205-209 (Pubitemid 36056594)
4. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1991) Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707-1712 (Pubitemid 21895530)
5. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 257:674-678
6. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Harber DA (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675
7. Gashler AL, Bonthron DT, Madden SL, Rauscher FJ III, Collins T, Sukhatme VP (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984-10988
8. Goldstein NS, Bassi D, Uzieblo A (2001) WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 116:246-252 (Pubitemid 33044330)
9. Goldstein NS, Uzieblo A (2002) WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 117:541-545 (Pubitemid 34823682)
10. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269
11. Harrington MA, Konicek B, Song A, Xia XL, Fredericks WJ, Rauscher FJ III (1993) Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem 268:21271-21275 (Pubitemid 23292317)
12. Hohenstein P, Hastie ND (2006) The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15:196-201
13. Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K (2006) Expression of Wilms' tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol 101:12-17
14. Idelman G, Glaser T, Roberts CT Jr, Werner H (2003) WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation. J Biol Chem 278:3474-3482 (Pubitemid 36801264)
15. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071-3079 (Pubitemid 24328100)
16. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S (2001) Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61:921-925 (Pubitemid 32174404)
17. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ III, Hill DE, Haber DA (1993) Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90:5100-5104 (Pubitemid 23182984)
18. Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 protooncogene. EMBO J 18:3990-4003 (Pubitemid 29335852)
19. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H, Noguchi S (2002) High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8:1167-1171 (Pubitemid 34517654)
20. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Path 19:804 -814
21. Netinatsunthorn W, Hanprasertpong J, Dechsukhum C, Leetanaporn R, Geater A (2006) WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study. BMC Cancer 6:90
22. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND (2004) The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 13:463-471 (Pubitemid 38239797)
23. Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, Abeno S, Ikeba A, Takashima S, Tsujie M, Yamamoto H, Sakon M, Nezu R, Kawano K, Nishida S, Ikegame K, Kawakami M, Tsuboi A, Oka Y, Yoshikawa K, Aozasa K, Monden M, Sugiyama H (2004) Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci 95:583-587 (Pubitemid 39089639)
24. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H (1999) Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90:194-204 (Pubitemid 29112320)
25. Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, Abeno S, Kiyotoh E, Jomgeow T, Sekimoto M, Nezu R, Yoshikawa Y, Inoue Y, Hosen N, Kawakami M, Tsuboi A, Oka Y, Ogawa H, Souda S, Aozasa K, Monden M, Sugiyama H (2003) Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 94:712-717 (Pubitemid 37160929)
26. Oji Y, Yano M, Nakano Y, Abeno S, Nakatsuka S, Ikeba A, Yasuda T, Fujiwara Y, Takiguchi S, Yamamoto H, Fujita S, Kanato K, Ito K, Jomgeow T, Kawakami M, Tsuboi A, Shirakata T, Nishida S, Hosen N, Oka Y, Aozasa K, Monden M, Sugiyama H (2004) Overexpression of the Wilms' tumor gene WT1 in esophageal cancer. Anticancer Res 24:3103-3108 (Pubitemid 39390958)
27. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA (1993) The Wilms' tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4:415-420 (Pubitemid 23231493)
28. Piver MS, Baker TR, Piedmonte M, Sandecki AM (1991) Epidemiology and etiology of ovarian cancer. Semin Oncol 18:177-185
29. Sagarra RA, Andrade LA, Martinez EZ, Pinto GA, Syrjanen KJ, Derchain SF (2002) P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer. Int J Gynecol Cancer 12:720 -727
30. Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S (2000) Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 19:158-163 (Pubitemid 30212153)
31. Shimizu Y, Kamoi S, Amada S, Akiyama F, Silverberg SG (1998) Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 82:893-901 (Pubitemid 28104169)
32. Silverberg SG (2000) Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19:7-15
33. Sotobori T, Ueda T, Oji Y, Naka N, Araki N, Myoui A, Sugiyama H, Yoshikawa H (2006) Prognostic significance of Wilms' Tumor Gene (WT1) mRNA expression in soft tissue sarcoma. Cancer 106:2233-2240 (Pubitemid 43673246)
34. Tavassoli FA, Devilee P (eds) (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC, Lyon, pp 218-228
35. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
36. Tomic S, Ilic Forko J, Babic D, Sundov D, Kuret S, Andelinovic S (2003) c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Croat Med J 44:429-434 (Pubitemid 37092801)
37. Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, Asada M, Ikeba A, Nakatsuka S, Abeno S, Hosen N, Tomita Y, Aozasa K, Tamai N, Myoui A, Yoshikawa H, Sugiyama H (2003) Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci 94:271-276 (Pubitemid 36575894)
38. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJ III, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr (1993) Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms' tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA 90:5828-5832 (Pubitemid 23176256)
39. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T (1996) Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87:2878-2884 (Pubitemid 26102238)
40. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR (1996) Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 15:5606-5615 (Pubitemid 26385620)
41. Zapata-Benavides P, Tuna M, Lopez-Berestein G, Tari AM (2002) Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295:784-790
42. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213 (Pubitemid 36077915)